Fate Therapeutics Inc (FATE)

Industry Biotechnology

This stock can be held in an Investment ISA and an Investment Account

Sell

$1.13

Buy

$1.15

arrow-up$0.04 (+3.60%)

Prices updated at 13 Dec 2025, 00:34 EST

Prices minimum 15 mins delay

Prices in USD

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of programmed cellular immunotherapies for cancer and immune disorders.

NASDAQ

-1.69%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

In the news

Sharecast service unavailable

Press releases

Key dates

	Forecast date
Half yearly results	Aug 2026
Annual general meeting	May 2026
Annual report	Mar 2026
Final results	Mar 2026

	Previous date
Half yearly results	Aug 2025
Annual general meeting	May 2025
Annual report	Mar 2025
Final results	Mar 2025

Company reports

31 Dec 2023

Annual Report

30 Sep 2025

Quarterly Report

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.